Interindividual Variability in the Cardiac Expression of Anthracycline Reductases in Donors With and Without Down Syndrome
Adolfo Quiñones‐Lombraña(University at Buffalo, State University of New York), Javier G. Blanco(Biomedical Research Institute), James Kalabus(Ambrx (United States)), Almedina Redzematovic(Memorial Sloan Kettering Cancer Center), Daniel C. Ferguson(University at Buffalo, State University of New York), Rachael Hageman Blair(University at Buffalo, State University of New York)
Cited by 21
Related Papers
Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2011|366
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
|European Urology|2016|204
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma
|JAMA Oncology|2018|202
Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment
|Blood|2003|152
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
|JCI Insight|2017|129